Singapore markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
98.68+0.39 (+0.39%)
As of 01:23PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
45,548,000
43,075,000
34,608,000
31,904,000
30,578,000
Cost of revenue
19,109,000
18,537,000
15,003,000
13,231,000
12,706,000
Gross profit
26,439,000
24,538,000
19,605,000
18,673,000
17,872,000
Operating expenses
Research development
2,815,000
2,742,000
2,420,000
2,440,000
2,300,000
Selling general and administrative
11,359,000
11,324,000
9,696,000
9,765,000
9,744,000
Total operating expenses
16,227,000
16,113,000
14,248,000
14,141,000
14,222,000
Operating income or loss
10,212,000
8,425,000
5,357,000
4,532,000
3,650,000
Interest expense
527,000
533,000
546,000
670,000
826,000
Total other income/expenses net
302,000
276,000
111,000
121,000
-56,000
Income before tax
10,048,000
8,211,000
4,968,000
4,077,000
2,873,000
Income tax expense
1,494,000
1,140,000
497,000
390,000
539,000
Income from continuing operations
8,554,000
7,071,000
4,471,000
3,687,000
2,334,000
Net income
8,554,000
7,071,000
4,495,000
3,687,000
2,368,000
Net income available to common shareholders
8,554,000
7,071,000
4,495,000
3,687,000
2,368,000
Basic EPS
-
4.01
2.54
2.09
1.35
Diluted EPS
-
3.94
2.50
2.06
1.33
Basic average shares
-
1,764,082
1,771,230
1,762,503
1,755,619
Diluted average shares
-
1,789,000
1,786,000
1,781,000
1,770,000
EBITDA
-
12,282,000
8,841,000
7,761,000
6,977,000